LianBio Enters into Agreement with Bristol Myers Squibb for Mavacamten in China and Other Asian Markets - GlobeNewswire
globenewswire.comSubmitted by globenewswire9432 in business
LianBio to receive total upfront consideration of $350 millionLianBio Board of Directors to conduct strategic review of business SHANGHAI and...